These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. Perrin LH; Lambert PH; Miescher PA J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431 [TBL] [Abstract][Full Text] [Related]
7. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease. Velosa J; Miller K; Michael AF Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of C3 and Bf in IgA nephropathy. Rambausek M; van den Wall Bake AW; Schumacher-Ach R; Spitzenberg R; Rother U; van Es LA; Ritz E Nephrol Dial Transplant; 1987; 2(4):208-11. PubMed ID: 3118258 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of immunoglobulins and complements in formaldehyde-fixed and paraffin-embedded renal biopsy tissues; an adjunct for diagnosis of glomerulonephritis. Chowdhury AR; Ehara T; Higuchi M; Hora K; Shigematsu H Nephrology (Carlton); 2005 Jun; 10(3):298-304. PubMed ID: 15958046 [TBL] [Abstract][Full Text] [Related]
10. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy. Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194 [No Abstract] [Full Text] [Related]
11. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825 [TBL] [Abstract][Full Text] [Related]
12. IgA nephropathy in adults: immunohistologic findings and clinical course. Parai SK; Ghose T Can Med Assoc J; 1985 Jun; 132(12):1381-4. PubMed ID: 3891058 [TBL] [Abstract][Full Text] [Related]
13. Circulating Fc-receptor blocking factors in IgA nephropathies. Roccatello D; Coppo R; Piccoli G; Cordonnier D; Martina G; Rollino C; Picciotto G; Sena LM; Amoroso A Clin Nephrol; 1985 Apr; 23(4):159-68. PubMed ID: 3874036 [TBL] [Abstract][Full Text] [Related]
14. [Significance of IgM deposition in IgA nephropathy: an appraisal based on renal re-biopsy]. Liu Z; Li L Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):324-6, 24. PubMed ID: 2169982 [TBL] [Abstract][Full Text] [Related]
15. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. IV. Immunohistology. Vizjak A; Trnacević S; Ferluga D; Halilbasić A Kidney Int Suppl; 1991 Nov; 34():S68-74. PubMed ID: 1762338 [TBL] [Abstract][Full Text] [Related]
16. Participation of complement components in glomerular deposition in IgA nephropathy. Suzuki S Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1029-37. PubMed ID: 2615014 [TBL] [Abstract][Full Text] [Related]
18. Glomerular expression of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in patients with various forms of glomerulonephritis. Matsuda M; Shikata K; Makino H; Sugimoto H; Ota Z Lab Invest; 1996 Sep; 75(3):403-12. PubMed ID: 8804363 [TBL] [Abstract][Full Text] [Related]
19. [Immunoelectron microscopic studies of IgA nephropathy in children]. Tanaka M Hokkaido Igaku Zasshi; 1986 Jan; 61(1):83-93. PubMed ID: 3699683 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy. Ren J; Wang L; Chen Z; Ma ZM; Zhu HG; Yang DL; Li XY; Wang BI; Fei J; Wang ZG; Wen YM J Med Virol; 2006 May; 78(5):551-60. PubMed ID: 16555286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]